Gary A. Gintant

Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

Philip T. Sager, Gary A. Gintant, J. Rick Turner et al. · American Heart Journal · 2013 · 536 citations · Full text

Heart Failure, Cardiac Anaesthesia, White Paper +21

Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle.

D W Liu, Gary A. Gintant, Charles Antzelevitch · Circulation Research · 1993 · 462 citations · Full text

Cardiac Muscle, Engineering, Biomedical Engineering +21

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

Thomas Colatsky, Bernard Fermini, Gary A. Gintant et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 443 citations · Full text

Cardiac Muscle, Heart Failure, Herg Block +21

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

Ksenia Blinova, Qianyu Dang, Daniel Millard et al. · Cell Reports · 2018 · 358 citations · Full text

The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block

Ruth L. Martin, Jeff S. McDermott, Heinz J. Salmen et al. · Journal of Cardiovascular Pharmacology · 2004 · 179 citations

Cardiac Muscle, Heart Failure, Pharmacotherapy +17